Hunan Warrant Pharmaceutical Co. Ltd. A (688799) — Capital Reinvestment Ratio
Hunan Warrant Pharmaceutical Co. Ltd. A (688799) has a Capital Reinvestment Ratio of 1.64x as of December 2024, meaning it reinvests 2% of its operating cash flow (CN¥142.23 Million) in capital expenditures (CN¥233.87 Million). See Hunan Warrant Pharmaceutical Co. Ltd. A (688799) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hunan Warrant Pharmaceutical Co. Ltd. A Capital Reinvestment Ratio (2019–2024)
This chart tracks Hunan Warrant Pharmaceutical Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods. Check Hunan Warrant Pharmaceutical Co. Ltd. A investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Hunan Warrant Pharmaceutical Co. Ltd. A (2019–2024)
Year-by-year Capital Reinvestment Ratio for Hunan Warrant Pharmaceutical Co. Ltd. A from 2019 to 2024. For live market cap and broader valuation context, see 688799 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.64x | CN¥142.23 Million | CN¥233.87 Million | ▲ +233.4% |
| 2023 | 0.49x | CN¥214.44 Million | CN¥105.76 Million | ▼ -41.8% |
| 2022 | 0.85x | CN¥155.65 Million | CN¥131.85 Million | ▲ +5.5% |
| 2021 | 0.80x | CN¥114.72 Million | CN¥92.10 Million | ▲ +56.3% |
| 2020 | 0.51x | CN¥104.66 Million | CN¥53.75 Million | ▲ +146.2% |
| 2019 | 0.21x | CN¥116.66 Million | CN¥24.34 Million | — |